Neuroimaging Technique Identifies Concussion-Related Brain Disease in Living Brain
September 16, 2014
Detection while patient is still alive improves accuracy of diagnosis and enables estimation of prevalence and risk
Mount Sinai Researchers Lead International Advisory Committee To Define The Clinical Course of Multiple Sclerosis
May 28, 2014
Re-examination of standardized multiple sclerosis descriptions published in 1996 to influence future research studies and clinical practice
Mount Sinai Researchers Identify Subtle Changes that May Occur in Neural Circuits Due to Cocaine Addiction
May 7, 2014
Research May Offer a Unique Pathway for Targeting New Therapeutics for Addiction Treatment
Mount Sinai Researchers Identify Genetic Alterations in Shared Biological Pathways as Major Risk Factor for Autism Spectrum Disorder
April 24, 2014
A substantial proportion of risk for developing autism spectrum disorders (ASD), resides in genes that are part of specific, interconnected biological pathways, according to researchers from the Icahn School of Medicine at Mount Sinai.
Intravenously Administered Ketamine Shown to Reduce Symptoms of Chronic Post-Traumatic Stress Disorder
April 16, 2014
Researchers from Mount Sinai demonstrate proof of concept for new, rapidly-acting pharmacotherapy for treatment of PTSD.
Susan B. Bressman, MD, Honored as "National Physician of the Year" By Castle Connolly Medical, Ltd., Publisher of the Annual America's Top Doctors® Guides
April 1, 2014
Dr. Bressman was recognized at the Ninth Annual Castle Connolly Medical Ltd. National Physician of the Year Awards on March 31.
Icahn School of Medicine at Mount Sinai Appoints A Director for the new Institute for Critical Care Medicine
February 26, 2014
Stephan A. Mayer, MD, joins Mount Sinai as director of the new institute.
Avoiding Harmful Byproducts of Heat-Processed Foods Protects Against Risk of Alzheimer’s Disease and Diabetes
February 24, 2014
Modifying dietary intake of Advanced Glycation Endproducts, or AGEs, bolsters body’s defenses against Alzheimer’s and Metabolic Syndrome.
With Large-Scale New Studies, Mount Sinai Scientists Help Underscore the Genetic Complexity in Schizophrenia
January 22, 2014
Largest exome studies of schizophrenia to date establish critical new scientific resources for biomedical community and the possibility of more tailored treatment for patients.
Novel Nanotherapy Breakthrough May Help Reduce Recurrent Heart Attacks and Stroke
January 20, 2014
Icahn School of Medicine at Mount Sinai designs HDL nanoparticle to deliver statin medication inside inflamed blood vessels to prevent repeat heart attacks and stroke.
Icahn School of Medicine at Mount Sinai Named to New NIH Stroke Research Network
December 20, 2013
Research collaborative network aims to expedite stroke clinical trials, build greater expertise in stroke.
Four Researchers from Icahn School of Medicine at Mount Sinai Among the 400 Most Highly Influential Biomedical Researchers in the World
November 25, 2013
Powerful researchers include Dr. Dennis S. Charney, Dr. Carlos Cordon-Cardo, Dr. Valentin Fuster, and Dr. Eric J. Nestler.
Two Mount Sinai Physicians Elected to the Institute of Medicine
October 24, 2013
Diane E. Meier, MD and Pamela Sklar, MD, PhD, recognized for Outstanding Professional Achievement and Commitment to Service.
Mount Sinai Researchers Publish New Edition of Psychiatry "Bible"
August 7, 2013
In light of the accelerated pace of discovery in understanding psychiatric illnesses, experts from Mount Sinai have published the 4th edition of Neurobiology of Mental Illness.
Mount Sinai Researchers Provide the First Comprehensive and Prospective Characterization of a Genetic Subtype of Autism
June 11, 2013
First study to describe clinical presentation of Phelan-McDermid Syndrome will help guide future research and clinical care
Pioneering Study Demonstrates Benefit of Imaging Technique in Identifying Mental Illness
June 5, 2013
MRI may be an effective way to diagnose mental illnesses such as bipolar disorder, according to experts from the Icahn School of Medicine at Mount Sinai.
Mount Sinai Researchers Identify Promising Drug Target for Depression
February 17, 2013
Decreased expression of a protein called Rac1 may be a primary cause of depression, according to a new study in human and mouse brains.
Facts about How Mount Sinai is Researching and Treating Brain Diseases
December 14, 2012
The Mount Sinai Medical Center is one of the world’s leading institutions in discovering better ways to prevent, diagnose, and treat serious brain diseases.
Short DNA Strands in the Genome May be Key to Understanding Human Cognition and Diseases
November 20, 2012
Previously discarded, human-specific “junk” DNA represents untapped resource in the study of diseases like Alzheimer’s and autism
Changes in Nerve Cells Caused by Social Isolation May Contribute to the Development of Mental Illness
November 11, 2012
Reduced production of myelin, a type of nerve fiber that is lost in diseases like MS, may also play a role in the development of mental illness.
Mount Sinai Researchers Unveil New Targets for Depression at Neuroscience 2012
October 15, 2012
Scientists presented important discoveries on the involvement of the immune system and dopamine on the onset of depression.
Mount Sinai Researchers Find Brain Mechanism Behind Opioid Addiction
October 5, 2012
Chronic morphine exposure has the opposite effect on the brain compared to cocaine in mice, providing new insight into the basis of opiate addiction
Mount Sinai Researcher Receives Prestigious National Institutes of Health Award
September 13, 2012
Anne Schaefer, MD, PhD, Assistant Professor of Neuroscience and Psychiatry, has been recognized with the Director's New Innovator Award.
Researchers Identify Area Of The Brain That Processes Empathy
September 1, 2012
An international team led by Mount Sinai School of Medicine has shown that one area of the brain is the only activity center of empathy.
Researchers Rediscover Potential of Rejected Alzheimer’s Drug to Arrest Progression of Disease in Mice
August 8, 2012
Study Suggests that Latrepirdine, Which Previously Failed in Clinical Trials, May Be Successful if Tested on Patients with Earlier Stages of the Disease
Wayne Goodman, MD, Receives Career Achievement Award from International OCD Foundation
July 28, 2012
The honor was presented to Dr. Goodman at the 19th Annual International OCD Foundation Conference in Chicago.
Mount Sinai Researcher Receives Career-Starter Research Grant for 2012-2013
June 20, 2012
Hirofumi Morishita, MD, PhD, receives a Career-Starter Research Grant for 2012-2013 from the Knights Templar Eye Foundation.
Mount Sinai Performs First Imaging Test to Detect Alzheimer's Disease in the Clinical Setting
June 20, 2012
The new technique is expected to play a critical role in Alzheimer's disease diagnosis and in research leading to a cure.
Gene that Causes Type 2 Diabetes May Also Cause Alzheimer’s
July 18, 2011
Researchers have found that a gene that causes diabetes kills nerve cells in the brain, possibly resulting in Alzheimer’s disease.
A Natural Chemical Found in Grape Seeds May Prevent Development or Progression of Alzheimer’s
July 15, 2011
Mount Sinai researchers found that polyphenols, a natural extract found in grapes, may help prevent or treat Alzheimer’s disease.
Mount Sinai Celebrates the “Topping Off” of the New Center for Science and Medicine Building
February 7, 2011
Set to open in 2012, CSM will bring nearly a half-million square-feet of new, state-of-the-art medical research and clinical facilities to Mount Sinai.
Mount Sinai Researchers Find That Little-Studied Gene May Boost Long-Term Memory and Enhance Cognition
January 26, 2011
Treatment with a gene called IGF-II significantly improved long-term memory. When the gene was blocked, long-term memories could not form.
Mount Sinai Researchers Make Groundbreaking Discovery on Origin of Brain’s Immune Cells
October 21, 2010
New study could lead to new treatments for degenerative brain diseases, such as Alzheimer’s, and autoimmune disorders, such as multiple sclerosis.
Mount Sinai Researcher Awarded Renowned Institute of Medicine Prize for Outstanding Achievements in Improving Mental Health
October 11, 2010
Dr. Eric Nestler honored for his work and achievements in addiction science.
Antihypertensive Drugs May Protect against Alzheimer’s Disease and Promote Healthy Memory
June 24, 2010
Researchers at Mount Sinai School of Medicine have found that a blood pressure drug may lessen the impact of Alzheimer’s disease and promote healthy memory.
New Autism Susceptibility Genes Identified; Autism Genome Project Phase 2 Results Published in Nature
June 9, 2010
In collaboration with the Autism Genome Project, Mount Sinai has published phase 2 data on gene variants that may lead to new autism treatments.
Mount Sinai Researchers Identify First Drug to Demonstrate Effect in an Animal Model of a Type of Autism
May 20, 2010
Researchers from Mount Sinai School of Medicine have identified a drug that improves communication between nerve cells in a mouse model of an autism subtype.
Wayne K. Goodman, MD, Honored with Mysell Lecture By Harvard Medical School
March 24, 2010
Wayne K. Goodman, MD, Chair of the Department of Psychiatry at Mount Sinai, has been selected to deliver the prestigious Mysell Lecture at Harvard.
New Mount Sinai Support Groups Will Address the Needs of Parkinson's and Dystonia Patients and Their Caregivers
January 5, 2010
Mount Sinai launches four new support groups to assist patients with Parkinson's disease and dystonia. Topics of discussion will include nutrition, new therapies, and caregiver needs.
Mount Sinai Researcher Led Study to Determine If Drug Slows Progression of Parkinson's Disease
September 24, 2009
C. Warren Olanow, MD, Professor and Chairman Emeritus, Department of Neurology, led an 18-month study on whether a drug used to treat Parkinson's actually slows disease progression.
Mount Sinai Research Identifies Brain Mechanisms Associated with Borderline Personality Disorder
September 3, 2009
Through real-time imaging, researchers have collected evidence to suggest that neurological networks that help regulate emotion do not activate in patients with borderline personality disorder.
Mount Sinai Finds Differences in Brain Scans of Patients with Borderline Personality Disorder
March 5, 2009
New research conducted by Mount Sinai physicians suggests that the brain activity of people with borderline personality disorder is different from that of people without the disorder.
New Psychiatric Program at The Mount Sinai Medical Center Addresses Special Needs of Multiple Sclerosis Patients
February 26, 2009
The new program provides for an on-site psychiatrist to assist in the identification and management of psychiatric and psychological disorders in patients with MS, including depression.